Smoking and asbestos exposure are important risks for lung cancer. Several epidemiological studies have linked asbestos exposure and smoking to lung cancer. To reconcile and unify these results, we conducted a systematic review and meta-analysis to provide a quantitative estimate of the increased risk of lung cancer associated with asbestos exposure and cigarette smoking and to classify their interaction. Five electronic databases were searched from inception to May, 2015 for observational studies on lung cancer. All case-control (N = 10) and cohort (N = 7) studies were included in the analysis. We calculated pooled odds ratios (ORs), relative risks (RRs) and 95% confidence intervals (CIs) using a random-effects model for the association of asbestos exposure and smoking with lung cancer. Lung cancer patients who were not exposed to asbestos and non-smoking (A-S-) were compared with; (i) asbestos-exposed and non-smoking (A+S-), (ii) non-exposure to asbestos and smoking (A-S+), and (iii) asbestos-exposed and smoking (A+S+). Our meta-analysis showed a significant difference in risk of developing lung cancer among asbestos exposed and/or smoking workers compared to controls (A-S-), odds ratios for the disease (95% CI) were (i) 1.70 (A+S-, 1.31-2.21), (ii) 5.65; (A-S+, 3.38-9.42), (iii) 8.70 (A+S+, 5.8-13.10). The additive interaction index of synergy was 1.44 (95% CI = 1.26-1.77) and the multiplicative index = 0.91 (95% CI = 0.63-1.30). Corresponding values for cohort studies were 1.11 (95% CI = 1.00-1.28) and 0.51 (95% CI = 0.31-0.85). Our results point to an additive synergism for lung cancer with co-exposure of asbestos and cigarette smoking. Assessments of industrial health risks should take smoking and other airborne health risks when setting occupational asbestos exposure limits.
Introduction Methods
The study was conducted and reported using the PRISMA (S1 PRISMA Checklist) [34] and MOOSE [35] guidelines.
Search Strategy and study selection
We searched titles and abstracts PubMed, Embase, Scopus, ISI Web of Knowledge, and TOX-LINE databases from their inception to May 2015. Combinations of the following key words were used: asbestos, crocidolite, amosite, chrysotile, tremolite, actinolite, anthophyllite, cigarette, cigarette smoke, cigarette smoking, pipe, cigar, tobacco, tobacco smoking, lung cancer, mesothelioma, lung carcinoma, and lung adenocarcinoma. There was no language restriction. Additional studies were also hand-searched from bibliographies of the selected studies.
Inclusion and exclusion criteria
Studies were included if they met all of the following criteria: (1) original articles published in peer-reviewed journals; (2) human studies; (3) observational studies; (4) studies investigating associations between asbestos exposure and smoking with lung cancer, and; (5) studies reporting sufficient data for calculating odds ratios and relative risks. The studies not meeting the inclusion criteria described above were excluded. If there were duplicate populations, only the studies providing the most details, grater number of participants, followed populations for longer follow-up periods, or the most recently published were selected for meta-analysis. Two reviewers (YN, WT) independently appraised titles and abstracts retrieved from the comprehensive searches. The controversial reviews were discussed and resolved by a third reviewer (OL). If further details were required, the reviewers contacted the authors for more information.
Data Abstraction and Quality Assessment
Information extracted from each study included first author, publication year, geographic area, study type (hospital-based case-control, population-based case-control, nested case-control, retrospective cohort, prospective cohort, and cross-sectional), total number of cases, and controls, fiber type (chrysotile, crocidolite, tremolite), industry type, measurement of asbestos and/ or smoking exposure, asbestos exposure assessment method, definition of asbestos exposure and/or smoking, period of employment/exposure, measurement method (asbestos exposure, smoking), and classification of outcome. The Newcastle-Ottawa quality assessment scale (NOS) was used to assess the quality of the selected observational studies. The categories of NOS was based on selection of participants, comparability of study groups, and the exposure of interest (case-control studies) or outcome of interest (cohort studies) [36] . When each category is satisfied it attracts one or sometimes two 'star(s)' and a maximum of 9 stars for either casecontrol or cohort study, indicates the highest quality study [37] .
Statistical Analysis
Asbestos exposure was arbitrarily taken as more than 100 air-borne fiber-yr/ml of environmental air for >5% of their work time and cigarette smoking was categorized as smokers who smoked >15 cigarettes/day. Those subjects having lower and shorter fiber exposures and lower cigarette consumption were deemed as non-exposed or non-smokers, respectively.
Using the above cut-offs, subjects were placed into four groups: (1) those people not exposed to asbestos and non-smokers were classified as not exposed to asbestos and non-smoking (A-S-), (2) workers exposed asbestos and non-smokers were classified as asbestos-exposed and non-smoking (A+S-), (3) those not exposed to asbestos but smoked were grouped as non-exposed to asbestos and were smokers (A-S+), and (4) workers exposed to asbestos and smoked were classified as asbestos-exposed and smokers (A+S+). The primary outcome of the pooled analysis focused on comparing the summary effect of lung cancer risk in people without asbestos exposure and non-smoking versus co-exposure to asbestos and/or smoking as follows: (i) A+S-compared with A-S-(ii) A-S+ compared with A-S-, and (iii) A+S+ compared with A-S-and interaction between asbestos and smoking were evaluated using the Rothman Synergy Index [38] . Summary effect estimates were assessed discretely by averaging the natural logarithmic OR and/or RR weighted by their inverse variances. The pooled effect estimates were calculated using a random effects model by the method of DerSimonian and Laird [39] . Heterogeneity among selected studies was determined using the Q-statistic and I-squared tests [40] . I-squared (I 2 ) values of 25%, 50%, and 75% represented low, moderate, and high degrees of heterogeneity, respectively [41] . The meta-analysis of case-control and cohort studies were conducted separately due to differences in the nature of study design [42] .
Subgroup analyses were performed according to the geographic area (Europe, America, others), asbestos type, study design (hospital or population, retrospective, prospective), and stratification of smoking level were used to assess the impacts of study characteristics on outcomes. Publication bias was quantified using funnel plot, Begg's test and Egger's test, where p>0.05 for both tests was considered to have no significant publication bias [43, 44] . All analyses were performed using STATA software V.10.1 (Stata Corp, College Station, TX, USA).
Determination of interactive effect
For measurement of interaction, there are 2 models to calculate this: the additive and the multiplicative scales. If these yield more than additive and multiplicative, there is a positive interaction. If less than additive/multiplicative, it is referred to as a negative interaction. The word "synergistic" means the effect two exposures is greater than the combined effect of each exposure. Thus, the value of interaction is more than either the additive or the multiplicative scales as appropriate, i.e., either additive or multiplicative synergism.
The joint effect of exposure to asbestos and smoking was first examined by estimating odds ratio (ORs) and relative risk (RRs). To determine whether co-exposure to asbestos and smoking is an additive and multiplicative scale, the synergy (S) and multiplicative (V) indices were calculated as follow [38, 45] .
Synergy index (S)
Where X 0 is the odds ratio and/or relative risk for lung cancer among non-exposed to asbestos and non-smokers; X A is the corresponding value for lung cancer among asbestos exposure in non-smokers; X S is for lung cancer and smoking in those without asbestos-exposure; and X AS is for lung cancer and co-exposure to asbestos and smoking. The synergy index (S) is an interaction on an additive scale. The interpretation is S = 1 suggests no interaction between asbestos exposure and smoking on lung cancer; S >1 suggests a positive interaction (synergism); and S<1 suggests a negative interaction (i.e., antagonism). For the multiplicative index (V), it can be interpreted as either: when V = 1, there is no interaction on the multiplicative scale; when V >1, the multiplicative interaction is positive; or when V<1, it is negative. Confidence intervals (CIs) were calculated using the method of Rothman, and Andersson et al. [38, 45, 46] .
Results

Study Selection
We identified 2,499 records of which 2,479 were duplicated, irrelevant, review articles, case reports, non-human or experimental studies, or lacked lung cancer outcomes or lacking control groups, and were excluded. Five additional publications meeting the inclusion criteria were added from the bibliographies of the retrieved articles (Fig 1) . In the final review of 25 studies, we excluded 5 studies [47] [48] [49] [50] [51] due to duplicate populations, and 3 studies [52] [53] [54] had insufficient data. Only one by Kjuus et al [55] was selected of three articles [47, 48, 55] which analyzed the same data. Case-control studies by Bovenzi (1992 and 1993) [49, 56] [53, 54] were excluded because numbers of controls were missing. Therefore, a total of 17 studies (10 case-control and 7 cohort studies) were included for meta-analysis. The 13 included studies were identified using the search terms, and another 4 studies derived from their bibliographies.
Study Characteristics
The characteristics and information of the included studies are shown in Table 1 . The 10 casecontrol studies [22, 25, 27, 55, 56, [58] [59] [60] [61] [62] , contained 10,223 participants in all of which 4,768 were population-based controls, and 1,128 hospital-based controls. Seven cohort studies [23, 24, 26, 57, [63] [64] [65] had an aggregate of 64,924 participants, comprising of the 3,316 cases and 61,608 controls. In all the included studies asbestos exposure was occupational. Where reported, the average participant age was approximately 60 (range 40-80 y) for case control studies. Some [22, 60] reported the type of asbestos used (tremolite or mixed asbestos), while the remaining eight [25, 27, 55, 56, 58, 59, 61, 62] did not categorize the asbestos (Table 1 ). The settings for the exposure was occupational, either asbestos mines (one study [22] ), ship building/ repair (two studies [59, 62] ), textile production (one study [60] ), and the remaining six [25, 27, 55, 56, 58, 61 ] studies failed to specify. Environmental monitoring was measured by using the membrane filter method and were analyzed by phase contrast microscopy [25] but most studies relied on personal/telephone interview and/or questionnaire. Smoking habits of participants were quantified by personal/telephone interview and/or questionnaire. If the subject had already died, the appropriate information was sought from their next-of-kin or spouse (Table 2 ). There were seven cohort studies, and all of these collected asbestos exposure data prospectively and also prospectively for smoking data in six studies and retrospectively in one [64] . The mean follow-up period of cohort studies was 19.3 yr. Exposure was to chrysotile in three studies [23, 57, 65] , one study to crocidolite [26] , and the asbestos type was unspecified in remaining three studies [24, 63, 64] (Table 1) . Four studies [23, 26, 57, 65] were from mining and three studies [24, 63, 64] originated from factories making asbestos products. Workplace asbestos exposure was assessed by lung histology, counting fibers trapped by midget impingers or membrane filters [23, 57, 65] , a long-duration personal konimeter [26] , or postal questionnaires [63, 64] . Only one study assessed exposure by chest X-ray radiographs and a low FEV1 by spirometry [24] . Smoking was assessed by interviewing or questionnairing the workers or their next-of-kin ( Table 2 ). Diagnosis of lung cancer was confirmed by histological examination of lung biopsies, chest X-ray, CT scan, MRI, bronchoscopy, or thoracoscopy. Most studies classified lung cancer using the International Classification of Diseases (ICD), published by the World Health Organization (Table 3) .
Quality Assessment
The methodological quality of case-control studies was summarized as a mean NOS of 6 (range 5-7) and a score of 6.7 (range 6-8) for cohort studies (Table 1) .
Quantitative Synthesis
(i) Case-control studies: A random-effects meta-analysis of 10 studies [22, 25, 27, 55, 56, [58] [59] [60] [61] [62] revealed associations between asbestos exposure and/or smoking, and developing lung cancer. The summary odds ratio of (A+S-) workers compared with (A-S-) workers was 1.70 (95% CI = 1.31-2.21). The summary odds ratio of (A-S+) workers compared with (A-S-) was 5.65 (95% CI = 3.38-9.42). Additionally, the summary odds ratio of (A+S +) workers compared with (A-S-) workers was 8.70 (95% CI = 5.78-13.10). Evidence of heterogeneity was found in A-S+/A-S-and A+S+/A-S-groups (I 2 = 90.6%, p = 0.000 and I 2 = 78.7%, p = 0.000) (Fig 2A-2C ). As shown in Table 4 , the results of subgroup analyses according to different characteristics are in close agreement with our major findings. Such heterogeneity probably arises from the differing interaction effects across varying levels of smoking exposure. We stratified studies with similar smoking classification by subdivision into 3 levels: non-smokers (non-smoking or light smoking), moderate smokers (1-19 cigarettes/day) and heavy smokers (>20 cigarettes/day) ( Table 5 ). There were no differences between non-smokers 2.63 (95% 1.43-4.83) and light smokers 2.63 (95% 1.57-4.42) for exposed-asbestos group. But for both subgroups, the moderate and heavy smoking categories showed elevated odds ratios with asbestos exposure. (ii) Cohort studies: Seven studies [23, 24, 26, 57, [63] [64] [65] were included in our primary analysis (Fig 3A-3C ). The summary relative risks for lung cancer in the cohort studies of (A+S-) Interaction between asbestos exposure and cigarette smoking
Evaluation of interaction is summarized in Table 6 . All 17 studies provided data which enabled evaluation of the joint effects of co-exposure of both asbestos and cigarette smoking on the risk of lung cancer. For case-control studies, the interaction index of synergy (S) and multiplicative index (V) were 1.44 (95% CI = 1.26-1.77) and 0.91 (95% CI = 0.63-1.30), respectively, with corresponding values for the cohort studies of 1.11 (95% CI = 1.00-1.28) and 0.51 (95% = 0.31-0.85). These results suggest that the interaction between asbestos exposure and smoking can be a positive interaction on the additive scale (an additive synergistic effect). There was a suggestion of a negative multiplicative interaction for both case-control and cohort studies.
Notably our results do not show a multiplicative effect between the two known human carcinogens.
Discussion
Our results demonstrate a positive synergistic interaction on an additive scale between asbestos exposure and cigarette smoking in workers developing lung cancer (Table 6 ). Employees exposed to asbestos and having a history of smoking have a higher risk of developing lung cancer than those only exposed to one risk (either smoking or asbestos alone). In contrast, the multiplicative index for case-control studies was close to 1.0, although for cohort studies, a negative multiplication interaction is suggested (V = 0.51, 95%CI = 0.31-0.85). Some data suggests that smoking does not enhance mesothelioma [66] , which implies that the synergistic lung cancer risk arises from the two carcinogens interacting in the same lung tissue. There are several mediators contributing to cigarette smoke and asbestos-induced lung diseases. Both smoking [67] and asbestos [68] elicit chronic inflammation, which is central to tumorigenesis and is augmented through reduced active immunity, increased infections, and compromised tumor surveillance [69, 70] . Tobacco smoke causes inflammation through a vast [71, 72] . Symptoms of inflammation include oxidative stress, which is worse in blue asbestos (amosite, crocidolite, tremolite) containing Fe ions which generate additional reactive species through Fenton catalysis [73] .
The prolonged bio-persistence of these amphiboles further contributes to their greater carcinogenicity than chrysotile and other mineral fibers. Tobacco smoke also contains multiple carcinogens (e.g., 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or NNK, 1,3-butadiene, ethylene oxide, chromium, polonium-210, arsenic, ethyl carbamate, and hydrazine) that directly interact with DNA [74] . Thus, the common localized inflammatory actions of tobacco smoke and asbestos readily explains additive effects, while the additional actions (direct carcinogenesis and Fenton catalysis) of each insult could account for the additive synergistic interaction. The present study has some limitations which are mostly inherent in this type of study. Odds ratios were roughly estimated from the included studies where the measurement methods used and exposure classification varied between studies. For example there were several studies claiming that the duration of asbestos exposure was the same as the period of employment in the workplace. Therefore, short duration jobs reduce the validity and reliability of questionnaires about occupational history. Some studies [58, 60, 61] did not provide estimates of adjusted risks (age, sex, etc.). The methods used to quantitate exposures to asbestos and cigarette smoke were arbitrary and varied across studies. The type of asbestos used was usually not stated. The diagnosis for lung cancer used different criteria (by physician, chest xray, radiography, or information taken from the death certificate). In contrast, other studies have objective exposure and clinical criteria (e.g., Markowitz et al. [24] ). The type of lung cancer was rarely stated or even whether mesothelioma was excluded but mesothelioma was never explicitly included. Some case-control studies [55, 59] used control populations who had other diseases (e.g., myocardial infarction, bladder cancer, other malignant neoplasms or other lung disease). Most of these diseases are also smoking-related. Nevertheless, all case-control studies endeavored to match controls for confounders. Some studies have data derived from recalling events that took place 10 years or more before the interview/questionnaire, which raises the issue of recall bias and misclassification. Subgroup analysis by smoking level retained high heterogeneity (Table 5 ) probably due to different methods of data collection and measurement, uncertain duration of smoking (only daily number of cigarettes smoked quoted).
Nevertheless, our study has some strength. It includes new data and the selection criteria complied with the PRISMA and MOOSE guidelines to perform the first systematic review and meta-analysis. Our analysis differed from previous analyses because (i), the strict selection criteria and heterogeneity testing, (ii) testing for statistical interaction (additive and multiplicative). Most studies randomly enrolled greater numbers of control subjects from hospital registers or health authority databases thus reducing selection bias. One study [59] excluded participants who provided incomplete questionnaire data, were non-responders, or who had emigrated from the area. These unavoidable variations in the study population and diverse methods utilized readily explain the substantial heterogeneity we detected. While the most dangerous asbestos types are no longer used, other siliceous fibers and chrysotile (in developing nations) are still incorporated into many building products without clear long-term health assessments in humans. Workers exposed to chrysotile showed increased risk of lung cancer (Table 4 ) [75] . The scientific rigor of cohort studies has improved since the early asbestos work. However, the long latencies for asbestos-induced neoplasms [76] make retrospective study the only practical protocol. Cigarette smoke inhalation and hence airway exposure can be accurately assessed (cigarette numbers, inhalation, filters). However, our study reiterates the difficulty in accurately assessing actual airway exposure to asbestos and was best assessed in the Markowitz et al. study [24] . Personal monitors provided the best indication of exposure but ultimately, only random sputum fiber counts by public health agencies can provide unbiased and accurate measures of exposure. Another problem highlighted by Markowitz et al. [24] and our study is accurately diagnosing the end-stage pathology. Again, monitoring by independent public health authorities is the mechanism most likely to yield accurate reporting. In addition, potential confounders including life-style and especially local air quality data need collecting for the same cohorts.
Conclusion
The present meta-analysis collected and synthesized data currently available and revealed a positive interaction on an additive scale between asbestos exposure and smoking, while showing little evidence of an interaction on a multiplicative scale. The combined effect of asbestos exposure with moderate and heavy smoking in lung cancer suggested a strong positive interaction on an additive scale, i.e., an additive synergism.
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